Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • sudders
    replied
    I am also having the same problem in both splicing.diff and promotor.diff.

    I have 5 samples in each of two groups, but only 25M reads per sample (100bp paired end).

    Promoters

    Cufflinks 1.0.3

    OK 11,309
    NOTEST 8,637
    FAIL 648

    with 7,902 significant

    Cuffdiff 1.3

    OK 1,383
    NOTEST 10,243
    FAIL 8,948

    2 significant

    Splicing

    Cufflinks 1.0.3

    OK 13,996
    NOTEST 51,240
    FAIL 2,933

    8,645 genes with sig. differential splicing

    Cufflinks 1.3

    OK 1,017
    NOTEST 28,032
    FAIL 37,736
    LOWDATA 1,401

    6 genes with sig. differential splicing.

    Leave a comment:


  • New differential testing of cuffdiff/cufflinks since 1.3.0

    Hi all,

    I have been trying out the new 1.3 version of the cufflinks package to see if the testing for differential splicing/expression etc is improved.

    Now I expected a more stringent analysis, as announced, but I get mostly failed tests.

    I used the same reads.bam and annotation and the same parameters (5 biological replicates and 2 groups, 2x 100 bp PE reads, ~ 140mil per sample).

    This is my result with cuffdiff v1.0.3 for diff. promoter usage:

    191 FAIL
    13713 NOTEST
    4745 OK

    with 1403 Genes found with sign. diff. promoter usage.

    Now this is the cuffdiff v 1.3 result:

    5719 FAIL
    35 LOWDATA
    12301 NOTEST
    594 OK

    with 20 Genes found with sign. diff. promoter usage.

    It seems that the number of false positives is really reduced. The new version find only ~ 3.5% of genes tested to be differential. However, so many fail to be tested in the first place that the result is not really usable.

    Did anyone experience something similar? Is this failing of testing maybe related to my large dataset or the replicates?

    All the best,
    Sebastian

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
60 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
75 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
74 views
0 reactions
Last Post SEQadmin2  
Working...